Clinical Trial Update: A Study to Evaluate the Effects of Asoprisnil(J867) in Women With Uterine Fibroids Who Are Scheduled for a Hysterectomy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the effects of Asoprisnil (J867) in women with uterine fibroids scheduled for hysterectomy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Drugs mentioned

• Asoprisnil (J867) (asoprisnil)

Snippet

Sponsor: Abbott | Conditions: Uterine Fibroids, Leiomyoma | Phase 2 | Status: COMPLETED